MEDTRONIC DANMARK A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Bankruptcy risk for industry  1.1% 1.1% 1.1% 1.1% 1.1%  
Bankruptcy risk  2.7% 2.7% 2.0% 0.5% 0.5%  
Credit score (0-100)  61 60 67 99 99  
Credit rating  BBB BBB A AAA AAA  
Credit limit (mDKK)  0.0 0.0 0.0 23.5 25.4  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (mDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4

Net sales  602 553 560 582 592  
Gross profit  148 130 153 157 166  
EBITDA  148 130 -20.9 21.4 23.1  
EBIT  148 130 -20.9 21.4 23.1  
Pre-tax profit (PTP)  8.2 13.8 19.8 20.8 23.6  
Net earnings  8.2 13.8 14.5 15.3 17.6  
Pre-tax profit without non-rec. items  148 130 -18.8 20.8 23.6  

 
See the entire income statement

Balance sheet (mDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4

Tangible assets total  0.0 0.0 1.5 1.5 6.1  
Shareholders equity total  102 116 110 115 122  
Interest-bearing liabilities  0.0 0.0 76.0 91.1 100  
Balance sheet total (assets)  266 309 262 286 300  

Net Debt  0.0 0.0 -80.0 -71.8 -80.8  
 
See the entire balance sheet

Volume 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4

Net sales  602 553 560 582 592  
Net sales growth  10.6% -8.2% 1.3% 3.9% 1.7%  
Gross profit  148 130 153 157 166  
Gross profit growth  -16.5% -11.7% 17.5% 2.6% 5.9%  
Employees  0 0 198 188 201  
Employee growth %  0.0% 0.0% 0.0% -5.1% 6.9%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  266 309 262 286 300  
Balance sheet change%  -0.7% 16.2% -15.4% 9.2% 5.1%  
Added value  147.5 130.3 -20.9 21.4 23.1  
Added value %  24.5% 23.6% -3.7% 3.7% 3.9%  
Investments  0 0 1 -0 5  

Net sales trend  1.0 -1.0 1.0 2.0 3.0  
EBIT trend  4.0 5.0 -1.0 1.0 2.0  

Profitability 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
EBITDA %  24.5% 23.6% -3.7% 3.7% 3.9%  
EBIT %  24.5% 23.6% -3.7% 3.7% 3.9%  
EBIT to gross profit (%)  100.0% 100.0% -13.7% 13.6% 13.9%  
Net Earnings %  1.4% 2.5% 2.6% 2.6% 3.0%  
Profit before depreciation and extraordinary items %  1.4% 2.5% 2.6% 2.6% 3.0%  
Pre tax profit less extraordinaries %  24.5% 23.6% -3.4% 3.6% 4.0%  
ROA %  55.2% 45.3% -7.1% 7.9% 8.4%  
ROI %  55.2% 45.3% -8.4% 11.7% 12.2%  
ROE %  7.1% 12.7% 12.9% 13.6% 14.9%  

Solidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Equity ratio %  100.0% 100.0% 37.2% 35.6% 37.3%  
Relative indebtedness %  0.0% 0.0% 29.3% 31.4% 31.8%  
Relative net indebtedness %  0.0% 0.0% 1.4% 3.5% 1.3%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 382.5% -335.9% -349.7%  
Gearing %  0.0% 0.0% 69.0% 79.5% 81.8%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% -3.9% 0.8% 1.2%  

Liquidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Quick Ratio  0.0 0.0 1.9 1.9 1.8  
Current Ratio  0.0 0.0 1.9 1.9 1.8  
Cash and cash equivalent  0.0 0.0 156.1 162.9 180.7  

Capital use efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Trade debtors turnover (days)  0.0 0.0 49.3 57.9 54.8  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 46.4% 48.8% 49.7%  
Net working capital  0.0 0.0 126.1 131.3 129.8  
Net working capital %  0.0% 0.0% 22.5% 22.5% 21.9%  

Employee efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales / employee  0 0 3 3 3  
Added value / employee  0 0 -0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 -0 0 0  
EBIT / employee  0 0 -0 0 0  
Net earnings / employee  0 0 0 0 0